294 related articles for article (PubMed ID: 27736306)
21. Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications.
Neves M; Azevedo R; Lima L; Oliveira MI; Peixoto A; Ferreira D; Soares J; Fernandes E; Gaiteiro C; Palmeira C; Cotton S; Mereiter S; Campos D; Afonso LP; Ribeiro R; Fraga A; Tavares A; Mansinho H; Monteiro E; Videira PA; Freitas PP; Reis CA; Santos LL; Dieguez L; Ferreira JA
N Biotechnol; 2019 Mar; 49():77-87. PubMed ID: 30273682
[TBL] [Abstract][Full Text] [Related]
22. Profiling circulating tumour cells and other biomarkers of invasive cancers.
Poudineh M; Sargent EH; Pantel K; Kelley SO
Nat Biomed Eng; 2018 Feb; 2(2):72-84. PubMed ID: 31015625
[TBL] [Abstract][Full Text] [Related]
23. Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer.
Hyun KA; Koo GB; Han H; Sohn J; Choi W; Kim SI; Jung HI; Kim YS
Oncotarget; 2016 Apr; 7(17):24677-87. PubMed ID: 27013581
[TBL] [Abstract][Full Text] [Related]
24. Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture.
Song Y; Zhu Z; An Y; Zhang W; Zhang H; Liu D; Yu C; Duan W; Yang CJ
Anal Chem; 2013 Apr; 85(8):4141-9. PubMed ID: 23480100
[TBL] [Abstract][Full Text] [Related]
25. Real-time circulating tumor cells detection via highly sensitive needle-like cytosensor-demonstrated by a blood flow simulation.
Weng WH; Ho IL; Pang CC; Pang SN; Pan TM; Leung WH
Biosens Bioelectron; 2018 Sep; 116():51-59. PubMed ID: 29859397
[TBL] [Abstract][Full Text] [Related]
26. Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer.
Pesta M; Fichtl J; Kulda V; Topolcan O; Treska V
Anticancer Res; 2013 May; 33(5):2239-43. PubMed ID: 23645782
[TBL] [Abstract][Full Text] [Related]
27. Technologies for detection of circulating tumor cells: facts and vision.
Alix-Panabières C; Pantel K
Lab Chip; 2014 Jan; 14(1):57-62. PubMed ID: 24145967
[TBL] [Abstract][Full Text] [Related]
28. Neovasculature and circulating tumor cells dual-targeting nanoparticles for the treatment of the highly-invasive breast cancer.
Yao J; Feng J; Gao X; Wei D; Kang T; Zhu Q; Jiang T; Wei X; Chen J
Biomaterials; 2017 Jan; 113():1-17. PubMed ID: 27794222
[TBL] [Abstract][Full Text] [Related]
29. Molecular characterization of circulating tumor cells-from bench to bedside.
Li Y; Wu S; Bai F
Semin Cell Dev Biol; 2018 Mar; 75():88-97. PubMed ID: 28899718
[TBL] [Abstract][Full Text] [Related]
30. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.
Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C
Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508
[TBL] [Abstract][Full Text] [Related]
31. Insights on CTC Biology and Clinical Impact Emerging from Advances in Capture Technology.
Bailey PC; Martin SS
Cells; 2019 Jun; 8(6):. PubMed ID: 31174404
[TBL] [Abstract][Full Text] [Related]
32. Sensitive antibody-based CTCs detection from peripheral blood.
Shahneh FZ
Hum Antibodies; 2013; 22(1-2):51-4. PubMed ID: 24284308
[TBL] [Abstract][Full Text] [Related]
33. Engineering Biomimetic Biosensor Using Dual-Targeting Multivalent Aptamer Regulated 3D DNA Walker Enables High-Performance Detection of Heterogeneous Circulating Tumor Cells.
Jia L; Hu Q; Zhang T; Wang Z; Wu D; Xie X; Wang S
Small; 2023 Sep; 19(38):e2302542. PubMed ID: 37222122
[TBL] [Abstract][Full Text] [Related]
34. Isolation of DNA aptamers targeting N-cadherin and high-efficiency capture of circulating tumor cells by using dual aptamers.
Gao T; Ding P; Li W; Wang Z; Lin Q; Pei R
Nanoscale; 2020 Nov; 12(44):22574-22585. PubMed ID: 33174555
[TBL] [Abstract][Full Text] [Related]
35. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
[TBL] [Abstract][Full Text] [Related]
36. Multivalent DNA nanospheres for enhanced capture of cancer cells in microfluidic devices.
Sheng W; Chen T; Tan W; Fan ZH
ACS Nano; 2013 Aug; 7(8):7067-76. PubMed ID: 23837646
[TBL] [Abstract][Full Text] [Related]
37. Enumeration, Dielectrophoretic Capture, and Molecular Analysis of Circulating Tumor Cells.
Yee SS; Carpenter EL
Methods Mol Biol; 2017; 1634():193-202. PubMed ID: 28819852
[TBL] [Abstract][Full Text] [Related]
38. EpCAM-independent capture of circulating tumor cells with a 'universal CTC-chip'.
Chikaishi Y; Yoneda K; Ohnaga T; Tanaka F
Oncol Rep; 2017 Jan; 37(1):77-82. PubMed ID: 27840987
[TBL] [Abstract][Full Text] [Related]
39. Circulating tumor cells: a multifunctional biomarker.
Yap TA; Lorente D; Omlin A; Olmos D; de Bono JS
Clin Cancer Res; 2014 May; 20(10):2553-68. PubMed ID: 24831278
[TBL] [Abstract][Full Text] [Related]
40. Natural Biointerface Based on Cancer Cell Membranes for Specific Capture and Release of Circulating Tumor Cells.
Ding P; Wang Z; Wu Z; Zhou Y; Sun N; Pei R
ACS Appl Mater Interfaces; 2020 May; 12(18):20263-20270. PubMed ID: 32259427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
